Congenital Heart Diseases Clinical Trial
Official title:
The Protective Effects of Sevoflurane Application During CPB on Pediatric Patients Underwent Cardiac Surgery: a Randomized, Controlled, Blinded Clinical Trial
During repair of a congenital heart defect the child is exposed to myocardial hypoxia. Recent studies have suggested that the paediatric myocardium is more sensitive to hypoxia and cardioplegic arrest than the adult. The protective effect of halogenated agents on ischaemia and reperfusion injury has been investigated widely in adults. The investigators hypothesis that sevoflurane applied during cardiopulmonary bypass might afford better myocardial protection during paediatric cardiac surgery.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02503267 -
"Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects"
|
N/A | |
| Terminated |
NCT03437148 -
Non-Invasive Shunt Quantification in Interatrial Communication
|
N/A | |
| Active, not recruiting |
NCT06223321 -
The Role of Multislice Computed Tomography in Congenital Heart Diseases in Paediatric Age Group.
|
||
| Completed |
NCT03005626 -
Transition From Adolescents to Adulthood for Patients With Congenital Heart Diseases
|
N/A | |
| Completed |
NCT01619982 -
Pre-operative Prophylaxis With Vancomycin and Cefazolin in Pediatric Cardiovascular Surgery Patients
|
Phase 4 | |
| Recruiting |
NCT02542683 -
Physical Activity and Cognitive Development in Children
|
||
| Enrolling by invitation |
NCT02527811 -
Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery
|
Phase 4 |